Mass screening aims to catch silent killers early in pakistan

NCT ID NCT07676214

Not yet recruiting Knowledge-focused Sponsor: Getz Pharma Source: ClinicalTrials.gov ↗

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study screens adults aged 18 and older in suburban and peri-urban areas of Faisalabad, Pakistan, for four major noncommunicable diseases: diabetes, hypertension, obesity, and high cholesterol. Participants who are found to have these conditions are referred to doctors for standard treatment and followed for three months. The goal is to see if community-based screening and referral can improve early diagnosis and disease management.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this screening program could help reduce the burden of noncommunicable diseases in Pakistan by catching them early and guiding people to proper care.
What could go wrong
This is an observational screening study, not a treatment trial. It may not prove that screening alone improves long-term health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETE MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.